Abbott Laboratories (ABT)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 105.90 |
| Open | 106.50 |
| Bid | 0.00 x 1300 |
| Ask | 0.00 x 800 |
| Day's Range | 104.47 - 107.03 |
| 52 Week Range | 89.67 - 121.64 |
| Volume | |
| Avg. Volume | 5,865,919 |
| Market Cap | 182.662B |
| Beta (5Y Monthly) | 0.74 |
| PE Ratio (TTM) | 32.79 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 2.20 (2.09%) |
| Ex-Dividend Date | Apr 12, 2024 |
| 1y Target Est | N/A |
- Insider Monkey
Abbott Laboratories (NYSE:ABT) Q1 2024 Earnings Call Transcript
Abbott Laboratories (NYSE:ABT) Q1 2024 Earnings Call Transcript April 17, 2024 Abbott Laboratories isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Robert Ford – Chairman and Chief Executive Officer: Phil Boudreau – Senior Vice President, Finance and Chief Financial Officer: Bob […]
- Simply Wall St.
Abbott Laboratories First Quarter 2024 Earnings: EPS Beats Expectations
Abbott Laboratories ( NYSE:ABT ) First Quarter 2024 Results Key Financial Results Revenue: US$9.96b (up 2.2% from 1Q...
- GuruFocus.com
Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript Highlights: Surpassing Expectations ...
Abbott Laboratories reports robust Q1 performance with significant sales growth and upward revisions in annual forecasts.
© 2024 Yahoo. All rights reserved.